• BioTime Awarded $2.5 Million Grant from the Israel Innovation Authority for Continued …

    ALAMEDA, Calif.–(BUSINESS WIRE)–May 10, 2019–BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company …

    Read More
  • 0 0